pillbase.ru

MabCampath

Active substance: alemtuzumab

alemtuzumab

Centralised EU authorisationWithdrawn

Marketing holder: Genzyme Europe B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 4
  • Лемтрада®
    концентрат для приготовления раствора для инфузий, 10 мг/мл, 1.2 мл (original in Russian, GRLS)
    ЛП-003714
    Джензайм Европа Б.В.
  • Лемтрада®
    концентрат для приготовления раствора для инфузий, 10 мг/мл, 1.2 мл (original in Russian, GRLS)
    ЛП-№(004242)-(РГ-RU)
    Санофи Б.В.
  • Кэмпас
    концентрат для приготовления раствора для инфузий, 10 мг/мл, 3 мл (original in Russian, GRLS)
    П N016089/01
    Шеринг АГ
  • Кэмпас®
    концентрат для приготовления раствора для инфузий, 30 мг/мл, 1 мл (original in Russian, GRLS)
    ЛС-002440
    Джензайм Европа Б.В.
US 2
  • Campath
    INJECTION · ALEMTUZUMAB 30 mg/mL
    58468-0357
    Genzyme Corporation
  • LEMTRADA
    INJECTION, SOLUTION, CONCENTRATE · ALEMTUZUMAB 12 mg/1.2mL
    58468-0200
    Genzyme Corporation
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-2fa0-7120-be30-690aea2b300e,01a120c3-5e76-71f3-a556-d83ccc42e748,01a120c5-544f-72ce-b127-ec976e08bdc6,01a120c5-924c-7782-a32c-5cc87c4351d3;count=4 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12096-6195-729b-a6cc-7352d5acdb16,01a1209b-4fbb-7a16-a386-9eb5596a1387;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/000353
Registration status
Withdrawn
ATC code
L01XC04
Sources
  • product · EMA · EMEA/H/C/000353 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/000353 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/000353 · Verified 2026-10-09